Recap: CVS Health Q2 Earnings

Shares of CVS Health CVS rose 4.6% in pre-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share increased 39.68% year over year to $2.64, which beat the estimate of $1.92.

Revenue of $65,341,000,000 up by 3.01% year over year, which beat the estimate of $64,180,000,000.

Looking Ahead

The upcoming fiscal year's EPS expected to be between $7.14 and $7.27.

Conference Call Details

Date: Aug 05, 2020

Time: 08:00 AM

ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg30.jsp&referrer=https%3A%2F%2Finvestors.cvshealth.com%2Finvestors%2Fevents-and-presentations%2Fdefault.aspx&eventid=2465869&sessionid=1&key=B0666A1ECCC099A4FEB630C3B6845C0D&regTag=&sourcepage=register

Technicals

52-week high: $77.03

52-week low: $52.04

Price action over last quarter: Up 10.66%

Company Overview

CVS Health Corp provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing about 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with about 23 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNews
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!